Cambrex Corporation News Headlines

CBM 
$19.93
*  
0.30
1.48%
Get CBM Alerts
*Delayed - data as of Sep. 23, 2014 10:14 ET  -  Find a broker to begin trading CBM now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    CBM Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

OncoMed Pharmaceuticals (OMED) Jumps: Stock Up 5.4% - Tale of the Tape
9/23/2014 8:51:00 AM - Zacks.com

Integra to Buy Medtronic's MicroFrance, Xomed; Shares Up - Analyst Blog
9/22/2014 3:10:00 PM - Zacks.com

Cytori Therapeutics (CYTX) Jumps: Stock Rises 6.4% - Tale of the Tape
9/22/2014 9:39:00 AM - Zacks.com

Vertex Pharmaceuticals (VRTX) Jumps: Stock Rises 6.6% - Tale of the Tape
9/22/2014 8:51:00 AM - Zacks.com

Halozyme's PEGPH20 Study S1313 Clinical Hold Lifted by FDA - Analyst Blog
9/19/2014 5:20:00 PM - Zacks.com

VIVUS Inc. (VVUS) Rises: Stock Adds 12.4% in Session - Tale of the Tape
9/19/2014 9:32:00 AM - Zacks.com

Arena Pharmaceuticals, Inc. (ARNA) Jumps: Stock Rises 9.5% - Tale of the Tape
9/19/2014 9:11:00 AM - Zacks.com

ImmunoCellular Therapeutics (IMUC) Jumps: Stock Up 9% - Tale of the Tape
9/18/2014 9:58:00 AM - Zacks.com

Halozyme Therapeutics (HALO) Jumps: Stock Up 9.3% - Tale of the Tape
9/18/2014 9:39:00 AM - Zacks.com

Repros Therapeutics (RPRX) Crumbles: Stock Falls by 10.5% - Tale of the Tape
9/18/2014 8:51:00 AM - Zacks.com

Alder Biopharmaceuticals (ALDR) in Focus: Stock Up 5.2% - Tale of the Tape
9/18/2014 8:44:00 AM - Zacks.com

Five Prime Therapeutics' Novel Target Licensed by Glaxo - Analyst Blog
9/17/2014 6:00:00 PM - Zacks.com

Regeneron Gets Breakthrough Therapy Status for Eylea - Analyst Blog
9/17/2014 4:30:00 PM - Zacks.com

Should You Get Rid of Vital Therapies (VTL) Now? - Tale of the Tape
9/17/2014 8:53:00 AM - Zacks.com

Dendreon (DNDN) in Focus: Stock Up 9.4% - Tale of the Tape
9/16/2014 8:44:00 AM - Zacks.com

Eli Lilly's Cyramza Scores in Colorectal Cancer Study - Analyst Blog
9/15/2014 4:30:00 PM - Zacks.com

Genomic Health Reveals Positive Oncotype DX Test Results - Analyst Blog
9/15/2014 3:00:00 PM - Zacks.com

Cytokinetics (CYTK) Looks Strong: Stock Gains 17.2% - Tale of the Tape
9/11/2014 8:44:00 AM - Zacks.com

Xenoport/NIAAA Collaborate on Alcoholism Therapy - Analyst Blog
9/10/2014 4:55:00 PM - Zacks.com

ERBA Diagnostics (ERB) in Focus: Stock Up 7% - Tale of the Tape
9/10/2014 9:39:00 AM - Zacks.com

Stemline Therapeutics (STML) in Focus: Stock Up 12.3% - Tale of the Tape
9/10/2014 8:51:00 AM - Zacks.com

ZIOPHARM Oncology (ZIOP) in Focus: Stock Rises 10.4% - Tale of the Tape
9/8/2014 9:39:00 AM - Zacks.com

Keryx Biopharmaceuticals (KERX) Crumbles: Stock Falls by 5.5% - Tale of the Tape
9/8/2014 8:55:00 AM - Zacks.com

BioDelivery Sciences (BDSI) Jumps: Stock Rises 8.9% - Tale of the Tape
9/8/2014 8:51:00 AM - Zacks.com

Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint - Analyst Blog
9/5/2014 5:05:00 PM - Zacks.com